Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 20, Number 7—July 2014
Research

Borrelia miyamotoi sensu lato Seroreactivity and Seroprevalence in the Northeastern United States

Peter J. KrauseComments to Author , Sukanya Narasimhan, Gary P. Wormser, Alan G. Barbour, Alexander E. Platonov, Janna Brancato, Timothy Lepore, Kenneth Dardick, Mark Mamula, Lindsay Rollend, Tanner K. Steeves, Maria Diuk-Wasser, Sahar Usmani-Brown, Phillip Williamson, Denis S. Sarksyan, Erol Fikrig, Durland Fish, and the Tick Borne Diseases Group
Author affiliations: Yale School of Public Health, New Haven, Connecticut, USA (P.J. Krause, J. Brancato, L. Rollend, T.K. Steeves, M. Diuk-Wasser, D. Fish); Yale School of Medicine, New Haven (P.J. Krause, S. Narasimhan, M. Mamula, E. Fikrig); New York Medical College, Valhalla, New York, USA (G.P. Wormser); University of California, Irvine, California, USA (A.G. Barbour); Central Research Institute of Epidemiology, Moscow, Russia (A.E. Platonov); Nantucket Cottage Hospital, Nantucket, Massachusetts, USA (T. Lepore); Mansfield Family Practice, Mansfield, Connecticut, USA (K. Dardick); L2 Diagnostics, LLC, New Haven (S. Usmani-Brown); Creative Testing Solutions, Tempe, Arizona, USA (P. Williamson); State Medical Academy, Izhevsk, Russia (D.S. Sarksyan)

Main Article

Table 2

Number of false-positive Borrelia burgdorferi assay results for participants in various relapsing fever studies*

Borrelia burgdorferi assay No. participants seroreactive to B. burgdorferi/no. total (%)
B. miyamotoi (current study)�? B. hermsii (23) B. hermsii (24) B. recurrentis (24) B. recurrentis (25)
Whole-cell sonicate ELISA 7/36 (19) ND 7/11 (64) 3/11 (27) 5�?"7/11 (45�?"64)
C6 ELISA 6/35 (17)�?� 1/14 (7) ND ND ND
Whole-cell sonicate ELISA and Western blot 4/36 (11) 2/14 (14) ND ND ND

* ND, not determined.�?"�? Study participants had no history of Lyme disease within the 2 years before serum was obtained for testing.�?"�?�The quantity of 1 serum sample was insufficient to test.

Main Article

References
  1. Barbour  AG. Relapsing fever. In: Goodman JL, Dennis DT, Sonenshine DE, editors. Tick-borne diseases of humans. Washington (DC): ASM Press; 2005.
  2. Dworkin  MS, Schwan  TG, Anderson  DE. Tick-borne relapsing fever in North America. Med Clin North Am. 2002;86:417–33 . DOIGoogle Scholar
  3. Fukunaga  M, Takahashi  Y, Tsuruta  Y, Matsushita  O, Ralph  D, McClelland  M, Genetic and phenotypic analysis of Borrelia miyamotoi sp. nov., isolated from the ixodid tick Ixodes persulcatus, the vector for Lyme disease in Japan. Int J Syst Bacteriol. 1995;45:804–10 . DOIGoogle Scholar
  4. Scoles  GA, Papero  M, Beati  L, Fish  D. A relapsing fever group spirochete transmitted by Ixodes scapularis ticks. Vector Borne Zoonotic Dis. 2001;1:21–34 . DOIGoogle Scholar
  5. Bunikis  J, Tsao  J, Garpmo  U, Berglund  J, Fish  D, Barbour  AG. Typing of Borrelia relapsing fever group strains. Emerg Infect Dis. 2004;10:1661–4 . DOIGoogle Scholar
  6. Barbour  AG, Bunikis  J, Travinsky  B, Hoen  AG, Diuk-Wasser  MA, Fish  D, Niche partitioning of Borrelia burgdorferi and Borrelia miyamotoi in the same tick vector and mammalian reservoir species. Am J Trop Med Hyg. 2009;81:1120–31. DOIGoogle Scholar
  7. Mun  J, Eisen  RJ, Eisen  L, Lane  RS. Detection of a Borrelia miyamotoi sensu lato relapsing-fever group spirochete from Ixodes pacificus in California. J Med Entomol. 2006;43:120–3 . DOIGoogle Scholar
  8. Richter  D, Schlee  DB, Matuschka  FR. Relapsing fever–like spirochetes infecting European vector tick of Lyme disease agent. Emerg Infect Dis. 2003;9:697–701. DOIGoogle Scholar
  9. Platonov  AE, Karan  LS, Kolyasnikova  NM, Makhneva  N, Toporkova  MG, Maleev  VV, Humans infected with the relapsing fever spirochete Borrelia miyamotoi, Russia. Emerg Infect Dis. 2011;17:1816–23. DOIGoogle Scholar
  10. Gugliotta  JL, Goethert  HK, Berardi  VP, Telford  SR. Meningoencephalitis due to Borrelia miyamotoi in an elderly immunocompromised patient. N Engl J Med. 2013;368:240–5 . DOIGoogle Scholar
  11. Krause  PJ, Narasimhan  S, Wormser  GP, Rollend  L, Fikrig  E, Lepore  T, Human Borrelia miyamotoi infection in the United States. N Engl J Med. 2013;368:291–3 . DOIGoogle Scholar
  12. Chowdri  HR, Gugliotta  JL, Berardi  V, Goethert  H, Molloy  PJ, Sterling  SL, Borrelia miyamotoi presenting as human granulocytic anaplasmosis. A case report. Ann Intern Med. 2013;159:21–7. DOIGoogle Scholar
  13. Hovius  JW, de Wever  B, Sohne  M, Brouwer  M, Coumou  J, Wagemakers  A, A case of meningoencephalitis by the relapsing fever spirochete Borrelia miyamotoi in Europe. Lancet. 2013;382:658. DOIGoogle Scholar
  14. Sarksyan  DS, Platonov  AE, Karan  LS, Malinin  IE, Khaliltova  LI, Shakhov  VI, Clinical presentation of "new" tick-borne borreliosis caused by Borrelia miyamotoi [In Russian]. Ter Arkh. 2012;84:34–41 .
  15. Schwan  TG, Schrumpf  ME, Hinnebusch  BJ, Anderson  DE, Konkel  ME. GlpQ: an antigen for serological discrimination between relapsing fever and Lyme borreliosis. J Clin Microbiol. 1996;34:2483–92 .
  16. Krause  PJ, McKay  K, Gadbaw  J, Christianson  D, Closter  L, Lepore  T, Increasing health burden of human babesiosis in endemic sites. Am J Trop Med Hyg. 2003;68:431–6 .
  17. Horowitz  HW, Aguero-Rosenfeld  ME, Holmgren  D, McKenna  D, Schwartz  I, Cox  ME, Lyme disease and human granulocytic anaplasmosis coinfection: impact of case definition on coinfection rates and illness severity. Clin Infect Dis. 2013;56:93–9 . DOIGoogle Scholar
  18. Barbour  AG, Jasinskas  A, Kayala  MA, Davies  DH, Steere  A, Baldi  P, A genome-wide proteome array reveals a limited set of immunogens in natural infections of humans and white-footed mice with Borrelia burgdorferi. Infect Immun. 2008;76:3374–89 . DOIGoogle Scholar
  19. Hue  F, Ghalyanchi Langeroudi  A, Barbour  AG. Chromosome sequence of Borrelia miyamotoi, an uncultivable tick-borne agent of human infection. Genome Announc. 2013;1:e00713–13.
  20. Liang  FT, Steere  AC, Marques  AR, Johnson  BJ, Miller  JN, Philipp  MT. Sensitive and specific serodiagnosis of Lyme disease by enzyme-linked immunosorbent assay with a peptide based on an immunodominant conserved region of Borrelia burgdorferi VlsE. J Clin Microbiol. 1999;37:3990–6 .
  21. Magnarelli  LA, Meegan  JM, Anderson  JF, Chappell  WA. Comparison of an indirect fluorescent-antibody test with an enzyme-linked immunosorbent assay for serological studies of Lyme disease. J Clin Microbiol. 1984;20:181–4 .
  22. Dressler  F, Whalen  JA, Reinhardt  BN, Steere  AC. Western blotting in the serodiagnosis of Lyme disease. J Infect Dis. 1993;167:392–400. DOIGoogle Scholar
  23. Bacon  RM, Biggerstaff  BJ, Schreifer  M, Gilmore  RD, Philipp  MT, Steere  AC, Serodiagnosis of Lyme disease by kinetic enzyme-linked immunosorbent assay using recombinant VlsE1 or peptide antigens of Borrelia burgdorferi compared with 2-tiered testing using whole-cell lysates. J Infect Dis. 2003;187:1187–99. DOIGoogle Scholar
  24. Magnarelli  LA, Anderson  JF, Johnson  RC. Cross-reactivity in serological tests for Lyme disease and other spirochetal infections. J Infect Dis. 1987;156:183–8. DOIGoogle Scholar
  25. Magnarelli  LA, Lawrenz  M, Norris  SJ, Fikrig  E. Comparative reactivity of human sera to recombinant VlsE and other Borrelia burgdorferi antigens in class-specific enzyme-linked immunosorbent assays for Lyme borreliosis. J Med Microbiol. 2002;51:649–55 .
  26. Johnson  ST, Cable  RG, Tonnetti  L, Spencer  B, Rios  J, Leiby  DA. Seroprevalence of Babesia microti in blood donors from Babesia-endemic areas of the northeastern United States: 2000 through 2007. Transfusion. 2009;49:2574–82 . DOIGoogle Scholar
  27. Krause  PJ, Telford  S, Spielman  A, Sikand  VJ, Ryan  R, Christianson  D, Concurrent Lyme disease and babesiosis: evidence for increased severity and duration of illness. JAMA. 1996;275:1657–60. DOIGoogle Scholar
  28. Krause  PJ, McKay  K, Thompson  CA, Sikand  VJ, Lentz  R, Lepore  T, Disease-specific diagnosis of coinfecting tick-borne zoonoses: babesiosis, human granulocytic ehrlichiosis, and Lyme disease. Clin Infect Dis. 2002;34:1184–91. DOIGoogle Scholar
  29. Ackermann  R, Kabatzki  J, Boisten  HP, Steere  AC, Grodzicki  RL, Hartung  S, Ixodes ricinus spirochete and European erythema chronicum migrans disease. Yale J Biol Med. 1984;57:573–80 .
  30. Centers for Disease Control and Prevention. Case definitions for infectious conditions under public health surveillance. MMWR Recomm Rep. 1997;46(RR-10):1–55 .
  31. Zhang  JR, Hardham  JM, Barbour  AG, Norris  SJ. Antigenic variation in Lyme disease borreliae by promiscuous recombination of VMP-like sequence cassettes. Cell. 1997;89:275–85. DOIGoogle Scholar
  32. Salkeld  DJ, Cinkovich  S, Nieto  NC. Tick-borne pathogens in northwestern California, USA [letter]. Emerg Infect Dis. 2014;20:493–4. DOIGoogle Scholar

Main Article

1Members of the Tick Borne Diseases Group are listed at the end of this article.

Page created: May 06, 2014
Page updated: May 06, 2014
Page reviewed: May 06, 2014
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external